News

Gene TherapiesR&D project spotlight: Towards continuous manufacturing for high-dose, cost-efficient rAAV therapies
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2025202420232022 →
Regulatory News - October 2021Regulatory News - October 2021Regulatory News - September 2021Regulatory News - September 2021Press Release: AAV reference material to be produced at the Cell and Gene Therapy Catapult Braintree in collaboration with the National Institute for Biological Standards and ControlPress Release: AAV reference material to be produced at the Cell and Gene Therapy Catapult Braintree in collaboration with the National Institute for Biological Standards and ControlRegulatory News - August 2021Regulatory News - August 2021Regulatory News - July 2021Regulatory News - July 2021Regulatory News - June 2021Regulatory News - June 2021Press release: Cell and Gene Therapy Catapult brings together over 20 organisations with the aim to accelerate technology development and potentially lower cost in cell and gene therapy manufacturingPress release: Cell and Gene Therapy Catapult brings together over 20 organisations with the aim to accelerate technology development and potentially lower cost in cell and gene therapy manufacturingRegulatory News - May 2021Regulatory News - May 2021Regulatory News - April 2021Regulatory News - April 2021Regulatory news - March 2021Regulatory news - March 2021Regulatory news - February 2021Regulatory news - February 2021Regulatory News - January 2021Regulatory News - January 2021